monoclonal antibodies

You might be intrigued by an invited paper this week in Alzheimer’s & Dementia, which the editors feel “will change the field”. The paper explains how Alzheimer’s works, why prior trials failed, and offers a novel point of intervention. The paper has already generated more than 100 reprint requests prior to publication. The link to […]

I confess that I’ve yet to find time to continue through each of several age-related diseases. In partial recompense, let me offer the following, which is adapted from the quarterly newsletter that I put out for Telocyte. While it focuses on Alzheimer’s disease, the import is generic, applying to all age-related diseases. How Alzheimer’s works […]